Drug Information

Drug General Information
Drug ID
D0M0WJ
Former ID
DIB012571
Drug Name
Liposomal encapsulated doxorubicin (LED)
Indication Breast cancer; Prostate cancer [ICD9: 174, 175, 185; ICD10:C50, C61] Phase 2 [531792]
Company
NeoPharm
Target and Pathway
Target(s) DNA topoisomerase II Target Info Modulator [1572591]
References
Ref 531792Antitumor activity of liposome-encapsulated doxorubicin in advanced breast cancer: phase II study. J Natl Cancer Inst. 1990 Nov 7;82(21):1706-10.
Ref 1572591Interpreting expression profiles of cancers by genome-wide survey of breadth of expression in normal tissues. Genomics 2005 Aug;86(2):127-41.

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.